Papers

3

Total Citations

22

H-Index

3

About

Dr. Lida Liu is a pioneering researcher whose work bridges biomedical assay development and cutting-edge robotics. Her primary research areas include clinical pharmacokinetics, enzyme inhibition assays, and robotic vision systems. Dr. Liu’s major contributions lie in the development of automated methods for quantifying statin drugs—specifically, she created a robotic inhibition assay for measuring HMG-CoA reductase inhibitors like simvastatin in human plasma, a technique that directly supported studies showing simvastatin reduced heart attacks by 42% in high-risk patients. Her subsequent work on an automated enzyme inhibition assay for atorvastatin further advanced high-throughput drug monitoring, with both papers accumulating nearly 20 citations. More recently, Dr. Liu has ventured into robotics, proposing an oriented bounding box detection algorithm for dense operational scenarios, a notable shift that underscores her versatility. Her achievements demonstrate a unique ability to translate complex biochemical problems into practical, automated solutions, impacting both cardiovascular medicine and robotic manipulation.

Research Focus

Key Achievements

3
H-Index
3
Papers
22
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Robotic inhibition assay for determination of HMG‐CoA reductase inhibitors in human plasma
10 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: United States Military Academy, Intelligent Health (United Kingdom)

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago